About Hancock Jaffe Laboratories, Inc.

Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include The Bioprosthetic Heart Valve, The CoreoGraft, and The Venous Valve. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -0.48$ per share.

The book value per share is 0.14$

Hancock Jaffe Laboratories, Inc. website

Create a solid portfolio with HJLI

Add HJLI to your portfolio and optimize it!


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- 100.00% -7M -592.79% -8M -0.48 - - 16M 0.14 -6M - -6M